Regulation changes could impact access to antiretrovirals in Mexico
This article was originally published in Scrip
Executive Summary
Mexicans could benefit from access to cheaper antiretrovirals thanks to changes in regulations governing the sale of pharmaceuticals by foreign companies in Mexico. The changes were announced by the country's president, Felipe Calder�n, at the opening ceremony of the XVII International AIDS Conference in Mexico City on Sunday.